Company: BOLT
Filing Date: 2025-03-24
Form Type: 10-K
Source: 0000950170-25-043873
Chunk: 190

Company: Bolt Biotherapeutics, Inc.
Filing Date: 2025-03-24
Form: 10-K
Item: Item 1B
Chunk 190
---
The remaining information required by this Item, which will be set forth in our definitive proxy statement to be filed with the Securities and Exchange Commission within 120 days after our fiscal year ended December 31, 2024 under the captions “Proposal 1: Election of Directors”, “Executive Officers” and “Information Regarding the Board of Directors and Corporate Governance – Insider Trading Policy”, is incorporated herein by reference.

Item 11. Executive Compensation. 

The information required by this Item will be set forth in our definitive proxy statement to be filed with the Securities and Exchange Commission within 120 days after our fiscal year ended December 31, 2024 under the captions “Executive Compensation”, “Compensation Committee Interlocks and Insider Participation” and “Director Compensation” and is incorporated herein by reference.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. 

The information required by this Item will be set forth in our definitive proxy statement to be filed with the Securities and Exchange Commission within 120 days after our fiscal year ended December 31, 2024 under the caption “Security Ownership of Certain Beneficial Owners and Management” and is incorporated herein by reference.

Information regarding our equity compensation plans required by this item will be set forth in our definitive proxy statement to be filed with the Securities and Exchange Commission within 120 days after our fiscal year ended December 31, 2024 under the caption "Equity Compensation Plan Information," and is incorporated by reference.

Item 13. Certain Relationships and Related Transactions, and Director Independence. 

The information required by this Item will be set forth in our definitive proxy statement to be filed with the Securities and Exchange Commission within 120 days after our fiscal year ended December 31, 2024 under the captions and “Information Regarding the Board of Directors and Corporate Governance – Independence of the Board of Directors” and is incorporated herein by reference.

Item 14. Principal Accountant Fees and Services. 

The information required by this Item will be set forth in our definitive proxy statement to be filed with the Securities and Exchange Commission within 120 days after our fiscal year ended December 31, 2024 under the caption “Ratification of Selection of Independent Registered Public Accounting Firm” and is incorporated herein by reference.

119

PART IV 

Item 15. Exhibits and Consolidated Financial Statement Schedules. 

(a)(1) The consolidated financial statements required to be filed by Items 8 and 15(c) of this Annual Report on Form 10-K, and filed her